Clinical trial / 2014
Green tea extract did not promote clearance of high-risk HPV or cervical lesions.
Ninety-eight women with persistent oncogenic HPV and cervical intraepithelial neoplasia received either daily Polyphenon E or placebo for four months. Complete clearance occurred in 17.1% (7 women) of the intervention group and 14.6% (6 women) receiving placebo, showing no significant difference between treatments. Furthermore, disease progression was observed in 14.6% of women taking the extract compared to 7.7% of those given placebo.
- Study type
- Randomized double-blind placebo-controlled trial
- Who was studied
- 98 women with persistent HPV and low-grade cervical lesions
- What was measured
- Clearance of oncogenic HPV and cervical intraepithelial neoplasia
THE PAPER
Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon E in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia.
Garcia FA, Cornelison T, Nuño T, Greenspan DL, Byron JW, Hsu CH, Alberts DS, Chow HH. Gynecol Oncol, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.